Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lumen Meds vs NuuVim

Lumen Meds
Graded #243

Lower grade

vs+6.699999999999989
NuuVim
Graded #100

Higher grade

The verdict

NuuVim takes it — 71.1/100 to 64.4/100.

NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuuVim +37
60
97
Dose & formulationNuuVim +44
52
96
Clinical oversightLumen Meds +34
76
42
Labs & monitoringLumen Meds +23
73
50
FulfillmentLumen Meds +9
70
61
Contract termsEven
55
55
Lumen Meds · left barNuuVim · right bar

The numbers

MetricLumen MedsNuuVim
WeighScore64.4/10071.1/100
GradeCC
Scorecard rank#243#100
SemaglutideNot disclosed$79/mo (all doses, compounded)
Tirzepatide$196/mo (compounded)$133/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Lumen Meds

Graded #243 · C

Strengths

  • LegitScript Certified
  • Free expedited cold shipping — important for GLP-1 cold-chain integrity
  • Lifestyle coaching included, not just medication dispensing
  • Orders labs when needed
  • Named legal entity (Lumen Meds LLC, Delaware) with a physical address

Where it loses points

  • $0 first-month promo — verify recurring billing and cancellation terms before committing
  • Standard ongoing semaglutide price not shown (only the first-month promo)
  • Per-state availability not listed
  • Pharmacy partners not named
  • Health quiz required before you see final per-patient pricing
NuuVim

Graded #100 · C

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where it loses points

  • No founder, CEO, medical director, or pharmacist-in-charge named
  • Refund and cancellation policy not surfaced on the site
  • Compounded medications are not FDA-approved
  • Doesn't disclose which pharmacy fills which drug or form
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard